Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 335

1.

Inter-observer agreement in identifying traction bronchiectasis on computed tomography: its improvement with the use of the additional criteria for chronic fibrosing interstitial pneumonia.

Tominaga J, Bankier AA, Lee KS, Leung AN, Remy-Jardin M, Akira M, Arakawa H, Boiselle PM, Franquet T, Fujimoto K, Gevenois PA, Goo JM, Grenier PA, Hatabu H, Ichikado K, Im JG, Johkoh T, Lee KN, Lynch DA, Noma S, Song JW, Sakai F, Sugiyama Y; Study Group of Diffuse Interstitial Lung Disease in Japan.

Jpn J Radiol. 2019 Sep 14. doi: 10.1007/s11604-019-00864-w. [Epub ahead of print]

PMID:
31522385
2.

Imaging of Precision Therapy for Lung Cancer: Current State of the Art.

Park H, Sholl LM, Hatabu H, Awad MM, Nishino M.

Radiology. 2019 Aug 6:190173. doi: 10.1148/radiol.2019190173. [Epub ahead of print]

PMID:
31385753
3.

Overlap of Genetic Risk Between Interstitial Lung Abnormalities and Idiopathic Pulmonary Fibrosis.

Hobbs BD, Putman RK, Araki T, Nishino M, Gudmundsson G, Gudnason V, Eiriksdottir G, Zilhao Nogueira NR, Dupuis J, Xu H, O'Connor GT, Manichaikul A, Nguyen J, Podolanczuk AJ, Madahar P, Rotter JI, Lederer DJ, Barr RG, Rich SS, Ampleford EJ, Ortega VE, Peters SP, O'Neal WK, Newell JD Jr, Bleecker ER, Meyers DA, Allen RJ, Oldham JM, Ma SF, Noth I, Jenkins RG, Maher TM, Hubbard RB, Wain LV, Fingerlin TE, Schwartz DA, Washko GR, Rosas IO, Silverman EK, Hatabu H, Cho MH, Hunninghake GM; COPDGene Investigators, ECLIPSE Investigators, SPIROMICS Research Group, and UK ILD Consortium.

Am J Respir Crit Care Med. 2019 Jul 24. doi: 10.1164/rccm.201903-0511OC. [Epub ahead of print]

PMID:
31339356
4.

Radiographic pulmonary vessel volume, lung function and airways disease in the Framingham Heart Study.

Synn AJ, Li W, San José Estépar R, Zhang C, Washko GR, O'Connor GT, Araki T, Hatabu H, Bankier AA, Mittleman MA, Rice MB.

Eur Respir J. 2019 Sep 12;54(3). pii: 1900408. doi: 10.1183/13993003.00408-2019. Print 2019 Sep.

PMID:
31248956
5.

Objectively Measured Chronic Lung Injury on Chest CT.

Harmouche R, Ash SY, Putman RK, Hunninghake GM, San Jose Estepar R, Martinez FJ, Choi AM, Lynch DA, Hatabu H, Han MK, Bowler RP, Kalhan R, Rosas IO, Washko GR, San Jose Estepar R; COPDGene Investigators.

Chest. 2019 Jun 22. pii: S0012-3692(19)31197-3. doi: 10.1016/j.chest.2019.05.020. [Epub ahead of print]

PMID:
31233744
6.

Detection of unwarranted CT radiation exposure from patient and imaging protocol meta-data using regularized regression.

Chen R, Paschalidis IC, Hatabu H, Valtchinov VI, Siegelman J.

Eur J Radiol Open. 2019 Jun 5;6:206-211. doi: 10.1016/j.ejro.2019.04.007. eCollection 2019.

7.

The incidence of ALK inhibitor-related pneumonitis in advanced non-small-cell lung cancer patients: A systematic review and meta-analysis.

Suh CH, Kim KW, Pyo J, Hatabu H, Nishino M.

Lung Cancer. 2019 Jun;132:79-86. doi: 10.1016/j.lungcan.2019.04.015. Epub 2019 Apr 10.

PMID:
31097098
8.

Significance of the Reverse Halo Sign in Immunocompromised Patients.

Thomas R, Madan R, Gooptu M, Hatabu H, Hammer MM.

AJR Am J Roentgenol. 2019 Sep;213(3):549-554. doi: 10.2214/AJR.19.21273. Epub 2019 Apr 30.

PMID:
31039026
9.

Tumor Volume Analysis as a Predictive Marker for Prolonged Survival in Anaplastic Lymphoma Kinase-rearranged Advanced Non-Small Cell Lung Cancer Patients Treated With Crizotinib.

Hida T, Dahlberg SE, Lydon CA, Hatabu H, Johnson BE, Awad MM, Nishino M.

J Thorac Imaging. 2019 Apr 12. doi: 10.1097/RTI.0000000000000413. [Epub ahead of print]

PMID:
30985604
10.

Interstitial lung abnormality in stage IV non-small cell lung cancer: A validation study for the association with poor clinical outcome.

Araki T, Dahlberg SE, Hida T, Lydon CA, Rabin MS, Hatabu H, Johnson BE, Nishino M.

Eur J Radiol Open. 2019 Mar 29;6:128-131. doi: 10.1016/j.ejro.2019.03.003. eCollection 2019.

11.

Rheumatoid Arthritis Disease Activity Predicting Incident Clinically Apparent Rheumatoid Arthritis-Associated Interstitial Lung Disease: A Prospective Cohort Study.

Sparks JA, He X, Huang J, Fletcher EA, Zaccardelli A, Friedlander HM, Gill RR, Hatabu H, Nishino M, Murphy DJ, Iannaccone CK, Mahmoud TG, Frits ML, Lu B, Rosas IO, Dellaripa PF, Weinblatt ME, Karlson EW, Shadick NA, Doyle TJ.

Arthritis Rheumatol. 2019 Sep;71(9):1472-1482. doi: 10.1002/art.40904. Epub 2019 Aug 4.

PMID:
30951251
12.

Time-resolved quantitative evaluation of diaphragmatic motion during forced breathing in a health screening cohort in a standing position: Dynamic chest phrenicography.

Hida T, Yamada Y, Ueyama M, Araki T, Nishino M, Kurosaki A, Jinzaki M, Honda H, Hatabu H, Kudoh S.

Eur J Radiol. 2019 Apr;113:59-65. doi: 10.1016/j.ejrad.2019.01.034. Epub 2019 Jan 31.

13.

Noncontrast Chest Computed Tomographic Imaging of Obesity and the Metabolic Syndrome: Part I Cardiovascular Findings.

Schlett CL, Nattenmüller J, Tsuchiya N, Vogel-Claussen J, Kauczor HU, Levin D, Hatabu H, Estépar JR, Wu MT, van Beek EJR, Schiebler ML; Representing the International Workshop for Pulmonary Functional Imaging (IWPFI).

J Thorac Imaging. 2019 Mar;34(2):116-125. doi: 10.1097/RTI.0000000000000391.

PMID:
30802234
14.

Deep Learning Applications in Chest Radiography and Computed Tomography: Current State of the Art.

Lee SM, Seo JB, Yun J, Cho YH, Vogel-Claussen J, Schiebler ML, Gefter WB, van Beek EJR, Goo JM, Lee KS, Hatabu H, Gee J, Kim N.

J Thorac Imaging. 2019 Mar;34(2):75-85. doi: 10.1097/RTI.0000000000000387.

PMID:
30802231
15.

Noncontrast Chest Computed Tomographic Imaging of Obesity and the Metabolic Syndrome: Part I Cardiovascular Findings.

Schlett CL, Nattenmüller J, Tsuchiya N, Vogel-Claussen J, Kauczor HU, Levin D, Hatabu H, Estépar JR, Wu MT, van Beek EJR, Schiebler ML; Representing the International Workshop for Pulmonary Functional Imaging (IWPFI).

J Thorac Imaging. 2019 Feb 15. doi: 10.1097/RTI.0000000000000391. [Epub ahead of print]

PMID:
30801454
16.

Decreased and slower diaphragmatic motion during forced breathing in severe COPD patients: Time-resolved quantitative analysis using dynamic chest radiography with a flat panel detector system.

Hida T, Yamada Y, Ueyama M, Araki T, Nishino M, Kurosaki A, Jinzaki M, Honda H, Hatabu H, Kudoh S.

Eur J Radiol. 2019 Mar;112:28-36. doi: 10.1016/j.ejrad.2018.12.023. Epub 2019 Jan 4.

17.

Noncontrast Chest Computed Tomographic Imaging of Obesity and the Metabolic Syndrome: Part II Noncardiovascular Findings.

Nattenmüller J, Schlett CL, Tsuchiya N, Reeder SB, Pickhardt PJ, Kramer H, Kauczor HU, Wielpütz MO, Seo JB, Hatabu H, van Beek EJR, Schiebler ML; Representing the International Workshop for Pulmonary Functional Imaging (IWPFI).

J Thorac Imaging. 2019 Mar;34(2):126-135. doi: 10.1097/RTI.0000000000000393.

PMID:
30720567
18.

M1b Disease in the 8th Edition of TNM Staging of Lung Cancer: Pattern of Single Extrathoracic Metastasis and Clinical Outcome.

Park H, Dahlberg SE, Lydon CA, Araki T, Hatabu H, Rabin MS, Johnson BE, Nishino M.

Oncologist. 2019 Aug;24(8):e749-e754. doi: 10.1634/theoncologist.2018-0596. Epub 2019 Jan 29.

PMID:
30696724
19.

Imaging Patterns Are Associated with Interstitial Lung Abnormality Progression and Mortality.

Putman RK, Gudmundsson G, Axelsson GT, Hida T, Honda O, Araki T, Yanagawa M, Nishino M, Miller ER, Eiriksdottir G, Gudmundsson EF, Tomiyama N, Honda H, Rosas IO, Washko GR, Cho MH, Schwartz DA, Gudnason V, Hatabu H, Hunninghake GM.

Am J Respir Crit Care Med. 2019 Jul 15;200(2):175-183. doi: 10.1164/rccm.201809-1652OC.

PMID:
30673508
20.

Incidental nonneoplastic parenchymal findings in patients undergoing lung resection for mass lesions.

Hung YP, Hunninghake GM, Miller ER, Putman R, Nishino M, Araki T, Hatabu H, Sholl LM, Vivero M.

Hum Pathol. 2019 Apr;86:93-101. doi: 10.1016/j.humpath.2019.01.002. Epub 2019 Jan 15.

PMID:
30658062
21.

Interstitial Lung Abnormality: Recognition and Perspectives.

Hatabu H, Hunninghake GM, Lynch DA.

Radiology. 2019 Apr;291(1):1-3. doi: 10.1148/radiol.2018181684. Epub 2018 Dec 18. No abstract available.

PMID:
30561274
22.

Increased Airway Wall Thickness in Interstitial Lung Abnormalities and Idiopathic Pulmonary Fibrosis.

Miller ER, Putman RK, Diaz AA, Xu H, San José Estépar R, Araki T, Nishino M, Poli de Frías S, Hida T, Ross J, Coxson H, Dupuis J, O'Connor GT, Silverman EK, Rosas IO, Hatabu H, Washko G, Hunninghake GM.

Ann Am Thorac Soc. 2019 Apr;16(4):447-454. doi: 10.1513/AnnalsATS.201806-424OC.

PMID:
30543456
23.

Automated image analysis tool for tumor volume growth rate to guide precision cancer therapy: EGFR-mutant non-small-cell lung cancer as a paradigm.

Nishino M, Wakai S, Hida T, Dahlberg SE, Ozaki M, Hatabu H, Tachizaki H, Johnson BE.

Eur J Radiol. 2018 Dec;109:68-76. doi: 10.1016/j.ejrad.2018.10.014. Epub 2018 Oct 23.

PMID:
30527314
24.

Imaging of Cancer Immunotherapy: Current Approaches and Future Directions.

Nishino M, Hatabu H, Hodi FS.

Radiology. 2019 Jan;290(1):9-22. doi: 10.1148/radiol.2018181349. Epub 2018 Nov 20.

PMID:
30457485
25.

Human Herpesvirus Alpha Subfamily (Herpes Simplex and Varicella Zoster) Viral Pneumonias: CT Findings.

Hammer MM, Gosangi B, Hatabu H.

J Thorac Imaging. 2018 Nov;33(6):384-389. doi: 10.1097/RTI.0000000000000364.

PMID:
30188334
26.

Interstitial lung abnormalities and physical function.

Axelsson GT, Putman RK, Miller ER, Araki T, Sigurdsson S, Gudmundsson EF, Eiríksdottír G, Siggeirsdottir K, Aspelund T, Launer LJ, Harris TB, Hatabu H, Gudnason V, Hunninghake GM, Gudmundsson G.

ERJ Open Res. 2018 Sep 3;4(3). pii: 00057-2018. doi: 10.1183/23120541.00057-2018. eCollection 2018 Jul.

27.
28.

Reply to "The Importance of the Reversed Halo Sign in the Diagnosis of Pulmonary Mucormycosis".

Hammer MM, Madan R, Hatabu H.

AJR Am J Roentgenol. 2018 Aug;211(2):W138. doi: 10.2214/AJR.18.19867. No abstract available.

PMID:
30036097
29.

Magnetic resonance angiography for the primary diagnosis of pulmonary embolism: A review from the international workshop for pulmonary functional imaging.

Tsuchiya N, van Beek EJ, Ohno Y, Hatabu H, Kauczor HU, Swift A, Vogel-Claussen J, Biederer J, Wild J, Wielpütz MO, Schiebler ML.

World J Radiol. 2018 Jun 28;10(6):52-64. doi: 10.4329/wjr.v10.i6.52. Review.

30.

Interstitial Features at Chest CT Enhance the Deleterious Effects of Emphysema in the COPDGene Cohort.

Ash SY, Harmouche R, Ross JC, Diaz AA, Rahaghi FN, Vegas Sanchez-Ferrero G, Putman RK, Hunninghake GM, Onieva Onieva J, Martinez FJ, Choi AM, Bowler RP, Lynch DA, Hatabu H, Bhatt SP, Dransfield MT, Wells JM, Rosas IO, San Jose Estepar R, Washko GR; COPDGene Investigators.

Radiology. 2018 Aug;288(2):600-609. doi: 10.1148/radiol.2018172688. Epub 2018 Jun 5.

31.

Sarcoid-Like Granulomatosis of the Lung Related to Immune-Checkpoint Inhibitors: Distinct Clinical and Imaging Features of a Unique Immune-Related Adverse Event.

Nishino M, Sholl LM, Awad MM, Hatabu H, Armand P, Hodi FS.

Cancer Immunol Res. 2018 Jun;6(6):630-635. doi: 10.1158/2326-6066.CIR-17-0715. Epub 2018 Apr 5.

32.

MRI for solitary pulmonary nodule and mass assessment: Current state of the art.

Ohno Y, Kauczor HU, Hatabu H, Seo JB, van Beek EJR; International Workshop for Pulmonary Functional Imaging (IWPFI).

J Magn Reson Imaging. 2018 Jun;47(6):1437-1458. doi: 10.1002/jmri.26009. Epub 2018 Mar 23. Review.

PMID:
29573050
33.

Pulmonary Mucormycosis: Radiologic Features at Presentation and Over Time.

Hammer MM, Madan R, Hatabu H.

AJR Am J Roentgenol. 2018 Apr;210(4):742-747. doi: 10.2214/AJR.17.18792. Epub 2018 Feb 22.

PMID:
29470162
34.

Association between acute respiratory disease events and the MUC5B promoter polymorphism in smokers.

Ash SY, Harmouche R, Putman RK, Ross JC, Martinez FJ, Choi AM, Bowler RP, Regan EA, Curtis JL, Han MK, Boucher RC, O'Neal WK, Hatabu H, Lynch DA, Rosas IO, Hunninghake GM, San Jose Estepar R, Washko GR; COPDGene Investigators.

Thorax. 2018 Nov;73(11):1071-1074. doi: 10.1136/thoraxjnl-2017-211208. Epub 2018 Feb 13.

PMID:
29440587
35.

Exposure to Traffic Emissions and Fine Particulate Matter and Computed Tomography Measures of the Lung and Airways.

Rice MB, Li W, Dorans KS, Wilker EH, Ljungman P, Gold DR, Schwartz J, Koutrakis P, Kloog I, Araki T, Hatabu H, San Jose Estepar R, O'Connor GT, Mittleman MA, Washko GR.

Epidemiology. 2018 May;29(3):333-341. doi: 10.1097/EDE.0000000000000809.

36.

Interstitial lung abnormalities and self-reported health and functional status.

Axelsson GT, Putman RK, Araki T, Sigurdsson S, Gudmundsson EF, Eiriksdottir G, Aspelund T, Miller ER, Launer LJ, Harris TB, Hatabu H, Gudnason V, Hunninghake GM, Gudmundsson G.

Thorax. 2018 Sep;73(9):884-886. doi: 10.1136/thoraxjnl-2017-210956. Epub 2018 Jan 9.

37.

Radiological features and metastatic patterns of thymic neuroendocrine tumours.

Araki T, Sholl LM, Hatabu H, Nishino M.

Clin Radiol. 2018 May;73(5):479-484. doi: 10.1016/j.crad.2017.11.025. Epub 2018 Jan 6.

PMID:
29310810
38.

Author reply: 'Response to: Pleural abnormalities in the Framingham Heart Study: prevalence and CT image features' by Araki et al.

Araki T, Hunninghake GM, Christiani DC, Hatabu H.

Occup Environ Med. 2018 Jan;75(1):77-78. doi: 10.1136/oemed-2017-104823. Epub 2017 Nov 9. No abstract available.

PMID:
29122924
39.

Disease Severity Dependence of the Longitudinal Association Between CT Lung Density and Lung Function in Smokers.

Diaz AA, Strand M, Coxson HO, Ross JC, San Jose Estepar R, Lynch D, van Rikxoort EM, Rosas IO, Hunninghake GM, Putman RK, Hatabu H, Yen A, Kinney GL, Hokanson JE, Silverman EK, Crapo J, Washko GR.

Chest. 2018 Mar;153(3):638-645. doi: 10.1016/j.chest.2017.10.012. Epub 2017 Oct 21.

40.

Histopathology of Interstitial Lung Abnormalities in the Context of Lung Nodule Resections.

Miller ER, Putman RK, Vivero M, Hung Y, Araki T, Nishino M, Washko GR, Rosas IO, Hatabu H, Sholl LM, Hunninghake GM.

Am J Respir Crit Care Med. 2018 Apr 1;197(7):955-958. doi: 10.1164/rccm.201708-1679LE. No abstract available.

41.

Thoracic Complications of Precision Cancer Therapies: A Practical Guide for Radiologists in the New Era of Cancer Care.

Nishino M, Hatabu H, Sholl LM, Ramaiya NH.

Radiographics. 2017 Sep-Oct;37(5):1371-1387. doi: 10.1148/rg.2017170015. Review.

42.

The MUC5B promoter polymorphism is associated with specific interstitial lung abnormality subtypes.

Putman RK, Gudmundsson G, Araki T, Nishino M, Sigurdsson S, Gudmundsson EF, Eiríksdottír G, Aspelund T, Ross JC, San José Estépar R, Miller ER, Yamada Y, Yanagawa M, Tomiyama N, Launer LJ, Harris TB, El-Chemaly S, Raby BA, Cho MH, Rosas IO, Washko GR, Schwartz DA, Silverman EK, Gudnason V, Hatabu H, Hunninghake GM.

Eur Respir J. 2017 Sep 11;50(3). pii: 1700537. doi: 10.1183/13993003.00537-2017. Print 2017 Sep.

43.

Tumor Response Dynamics of Advanced Non-small Cell Lung Cancer Patients Treated with PD-1 Inhibitors: Imaging Markers for Treatment Outcome.

Nishino M, Dahlberg SE, Adeni AE, Lydon CA, Hatabu H, Jänne PA, Hodi FS, Awad MM.

Clin Cancer Res. 2017 Oct 1;23(19):5737-5744. doi: 10.1158/1078-0432.CCR-17-1434. Epub 2017 Jul 5.

44.

Monitoring immune-checkpoint blockade: response evaluation and biomarker development.

Nishino M, Ramaiya NH, Hatabu H, Hodi FS.

Nat Rev Clin Oncol. 2017 Nov;14(11):655-668. doi: 10.1038/nrclinonc.2017.88. Epub 2017 Jun 27. Review.

45.

Difference in the craniocaudal gradient of the maximum pixel value change rate between chronic obstructive pulmonary disease patients and normal subjects using sub-mGy dynamic chest radiography with a flat panel detector system.

Yamada Y, Ueyama M, Abe T, Araki T, Abe T, Nishino M, Jinzaki M, Hatabu H, Kudoh S.

Eur J Radiol. 2017 Jul;92:37-44. doi: 10.1016/j.ejrad.2017.04.016. Epub 2017 Apr 27.

46.

Osimertinib in EGFR T790M-Positive Lung Cancer.

Nishino M, Hatabu H.

N Engl J Med. 2017 May 18;376(20):1992-3. doi: 10.1056/NEJMc1703339. No abstract available.

PMID:
28517914
47.

Clinical and Genetic Associations of Objectively Identified Interstitial Changes in Smokers.

Ash SY, Harmouche R, Putman RK, Ross JC, Diaz AA, Hunninghake GM, Onieva Onieva J, Martinez FJ, Choi AM, Lynch DA, Hatabu H, Rosas IO, San Jose Estepar R, Washko GR; COPDGene Investigators.

Chest. 2017 Oct;152(4):780-791. doi: 10.1016/j.chest.2017.04.185. Epub 2017 May 12.

48.

The Thymus: A Comprehensive Review-Erratum.

Nishino M, Ashiku SK, Kocher ON, Thurer RL, Boiselle PM, Hatabu H.

Radiographics. 2017 May-Jun;37(3):1004. doi: 10.1148/rg.2017174002. No abstract available.

PMID:
28493794
49.

Pleural abnormalities in the Framingham Heart Study: prevalence and CT image features.

Araki T, Yanagawa M, Sun FJ, Dupuis J, Nishino M, Yamada Y, Washko GR, Christiani DC, Tomiyama N, O'Connor GT, Hunninghake GM, Hatabu H.

Occup Environ Med. 2017 Oct;74(10):756-761. doi: 10.1136/oemed-2016-104178. Epub 2017 May 3.

50.

Co-clinical quantitative tumor volume imaging in ALK-rearranged NSCLC treated with crizotinib.

Nishino M, Sacher AG, Gandhi L, Chen Z, Akbay E, Fedorov A, Westin CF, Hatabu H, Johnson BE, Hammerman P, Wong KK.

Eur J Radiol. 2017 Mar;88:15-20. doi: 10.1016/j.ejrad.2016.12.028. Epub 2016 Dec 26.

Supplemental Content

Loading ...
Support Center